Precision Neuropsychiatry is a leading platform dedicated to advancing the integration of precision medicine and neuropsychiatry. The journal focuses on the innovative application of precision technologies—including biomarkers, neuroimaging, genomics, and AI-assisted diagnostics—in the personalized treatment of mental health disorders.
Precision Neuropsychiatry emphasizes the importance of translational medicine and interdisciplinary collaboration. It highlights research on the neural circuit mechanisms underlying psychiatric conditions and fosters the development of targeted therapeutic strategies. The journal aims to bridge the gap between cutting-edge scientific discoveries and their clinical implementation, driving forward a new era of individualized mental health care. Content accepted for publication should be related to the following areas of research:
- Molecular and Genetic Basis: Studies on genetic variants, epigenetic mechanisms, and molecular pathways associated with neuropsychiatric conditions, such as schizophrenia, depression, anxiety disorders, and neurodevelopmental disorders.
- Neuroimaging and Biomarkers: Research utilizing advanced neuroimaging techniques (e.g., fMRI, PET, MEG) to identify brain structural and functional alterations, as well as the development and validation of biological and psychological biomarkers for early diagnosis and prognosis.
- Psychopharmacology and Therapeutics: Investigations into the mechanisms of action of psychotropic drugs, personalized pharmacotherapy strategies, novel therapeutic targets, and innovative treatment modalities (e.g., neuromodulation, psychedelic-assisted therapy).
- Cognitive and Behavioral Neuroscience: Explorations of cognitive deficits, behavioral patterns, and their neural substrates in neuropsychiatric disorders, as well as the development of cognitive-behavioral interventions and rehabilitation programs.
- Digital Health and Data Science: Applications of digital technologies (e.g., mobile health, artificial intelligence, machine learning) in mental health assessment, monitoring, and intervention, and the analysis of large-scale datasets to uncover patterns and insights.
- Translational Research: Bridging basic scientific discoveries with clinical applications, including preclinical studies in animal models and clinical trials aimed at improving patient outcomes.
Precision Neuropsychiatry publishes Research Articles, Review Articles, Study Protocols, Commentaries, Editorials, Case Reports and Letters to the Editor.
Funded By
Journal Contact: Jing Li
Email: ashujing@163.com
Published By
The journal is published by Compuscript Ltd.
For more information please contact:
Morgan Lyons
Bay 11a, Shannon Industrial Est., Shannon, Co. Clare, Ireland
Tel: +353 61 472743
E-mail: m.lyons@compuscript.com
Open Access
Precision Neuropsychiatry publishes as a platinum open access journal. This means that permanent and free access to published scientific works for readers and no publication fees for the authors – it is 100% free. See full licencing and copyright information here. [LINK TO LICENCING AND COPYRIGHT PAGE]
Article Types Published
Precision Neuropsychiatry publishes Research Articles, Review Articles, Study Protocols, Commentaries, Editorials, Case Reports and Letters to the Editor.